ABEONA THERAPEUTICS INC (ABEO)

The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors

Unusual volume stocks in Monday's session

Unusual volume stocks in Monday's session

Friday 4/26 Insider Buying Report: MSCI, ABEO

On Wednesday, there are stocks with unusual volume. Let's take a look.

Unusual volume stocks in Wednesday's session

Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps.

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.

Why Is Affirm (AFRM) Stock Moving Today?

Affirm stock is falling on Tuesday as AFRM investors react to BNPL loan service One being added to Walmart's retail stores.

Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today?

Greenwave Technology Solutions stock is down on Tuesday as GWAV investors react to a registered direct offering and private placement.

Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?

Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.

Tuesday's pre-market session: top gainers and losers

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!

Monday's after hours session: top gainers and losers

The regular session of the US market on Monday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Abeona Therapeutics Provides Regulatory Update on Pz-cel

Abeona Therapeutics Provides Regulatory Update on Pz-cel

Receives FDA Complete Response Letter (CRL) based on need for additional CMC information CRL did not identify deficiencies related to clinical efficacy...

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, April 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive...

ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Abeona Therapeutics (NASDAQ:ABEO) just reported results for the fourth quarter ...

ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023

ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections

- FDA completed Pre-License Inspection of Abeona’s Cleveland manufacturing facility, as well as inspection of clinical trial sites for pz-cel pivotal Phase 3 VIITAL™ study -

Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections

- FDA completed Pre-License Inspection of Abeona’s Cleveland manufacturing facility, as well as inspection of clinical trial sites for pz-cel pivotal Phase 3 VIITAL™ study -

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, March 05, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive...

Top Buys by Top Brass: Chief Executive Officer Seshadri's $169.2K Bet on ABEO

Wednesday 2/7 Insider Buying Report: ABEO, AFL

Abeona Therapeutics says CEO Seshadri buys 20K shares (NASDAQ:ABEO)

Abeona Therapeutics' CEO purchases 20K shares, increasing his ownership to 528.3K shares. Recent insider trade activity involved one sale.

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive...

Abeona issues update on FDA market application for pz-cel (NASDAQ:ABEO)

Abeona Therapeutics (ABEO) said that the FDA currently does not intend to hold an advisory panel meeting to discuss its Biologics License Application for its th

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)

Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)

- On track for PDUFA target action date of May 25, 2024 - CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today...

RSI Alert: Abeona Therapeutics (ABEO) Now Oversold

Abeona Therapeutics announces $50M credit facility (NASDAQ:ABEO)

Abeona Therapeutics secures a $50M credit facility to fund its preparations for launch and commercialization of pz-cel for RDEB treatment in the US.

Abeona Therapeutics Announces $50 Million Credit Facility

Abeona Therapeutics Announces $50 Million Credit Facility

CLEVELAND, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has entered into a $50 million credit...